ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 82 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,602,367 | -25.8% | 4,319,049 | 0.0% | 0.01% | -30.8% |
Q3 2022 | $2,159,525 | -14.4% | 4,319,049 | 0.0% | 0.01% | -7.1% |
Q2 2022 | $2,523,188 | +254.4% | 4,319,049 | +331.9% | 0.01% | +366.7% |
Q1 2022 | $712,000 | -46.1% | 1,000,000 | 0.0% | 0.00% | -40.0% |
Q4 2021 | $1,320,000 | -42.6% | 1,000,000 | 0.0% | 0.01% | -37.5% |
Q3 2021 | $2,300,000 | -47.6% | 1,000,000 | 0.0% | 0.01% | -46.7% |
Q2 2021 | $4,390,000 | -39.5% | 1,000,000 | 0.0% | 0.02% | -46.4% |
Q1 2021 | $7,260,000 | +68.1% | 1,000,000 | 0.0% | 0.03% | +47.4% |
Q4 2020 | $4,320,000 | +5.1% | 1,000,000 | 0.0% | 0.02% | -9.5% |
Q3 2020 | $4,110,000 | -31.5% | 1,000,000 | 0.0% | 0.02% | -41.7% |
Q2 2020 | $6,000,000 | -20.3% | 1,000,000 | 0.0% | 0.04% | -35.7% |
Q1 2020 | $7,530,000 | -45.2% | 1,000,000 | 0.0% | 0.06% | -37.8% |
Q4 2019 | $13,750,000 | +15.7% | 1,000,000 | 0.0% | 0.09% | +3.4% |
Q3 2019 | $11,880,000 | -15.1% | 1,000,000 | 0.0% | 0.09% | -13.0% |
Q2 2019 | $13,990,000 | -21.8% | 1,000,000 | 0.0% | 0.10% | -19.4% |
Q1 2019 | $17,880,000 | +13.7% | 1,000,000 | 0.0% | 0.12% | +14.8% |
Q4 2018 | $15,730,000 | – | 1,000,000 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |